Robert Ticktin's most recent trade in PMV Pharmaceuticals Inc was a trade of 319,270 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc | Robert Ticktin | General Counsel & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 319,270 | 319,270 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Robert Ticktin | General Counsel & COO | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 01 Jul 2025 | 23,151 | 98,695 | - | 1.1 | 24,651 | Common Stock |